RAFA
Price:
$0.051
Market Cap:
$4.48M
Rafarma Pharmaceuticals, Inc. is a diversified pharmaceutical enterprise that manufactures and distributes a range of medicinal products, including generic antibiotics and specialized drugs, within the Russian market. Its product portfolio encompasses anti-cancer medications, cephalosporin-derived compounds, and non-beta-lactam antibiotics. These are available in various formats such as injectable solutions, ampoules, pediatric suspensions, oral tablets, and capsules. Additionally, Rafarma develops and supplies treatments for injuries, ocular inflammatory conditions, and immunological ailments. In a collaborative effort with PlantEXT Ltd., the company is involved in the research and producti...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-12-11
Stock Exchange
OTC
Ticker
RAFA
According to Rafarma Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.64. This represents a change of -113.29% compared to the average of 27.39 of the last 4 quarters.
The mean historical PE Ratio of Rafarma Pharmaceuticals, Inc. over the last ten years is -15.63. The current -3.64 PE Ratio has changed 2.23% with respect to the historical average. Over the past ten years (40 quarters), RAFA's PE Ratio was at its highest in in the March 2022 quarter at 1.37K. The PE Ratio was at its lowest in in the September 2022 quarter at -9.70.
Average
-15.63
Median
7.33
Minimum
-156.30
Maximum
84.01
Discovering the peaks and valleys of Rafarma Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 982.25%
Maximum Annual PE Ratio = 84.01
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -156.30
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 6.90 | -74.51% |
| 2024 | 27.06 | -67.79% |
| 2023 | 84.01 | 982.25% |
| 2022 | 7.76 | 22.61% |
| 2021 | 6.33 | -36.25% |
| 2020 | 9.93 | -9.56% |
| 2020 | 10.98 | -108.09% |
| 2019 | -135.73 | 685.47% |
| 2018 | -17.28 | -88.94% |
| 2014 | -156.30 | -Infinity% |
The current PE Ratio of Rafarma Pharmaceuticals, Inc. (RAFA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
39.32
5-year avg
26.41
10-year avg
-15.63
Rafarma Pharmaceuticals, Inc.’s PE Ratio is less than Pharmadrug Inc. (-2.86), less than Bio Essence Corporation (8.70), less than StateHouse Holdings Inc. (-0.11), less than Revive Therapeutics Ltd. (-1.23), less than Ubiquitech Software Corp. (1.63), less than Integrated Cannabis Solutions, Inc. (9.37), less than LiveWire Ergogenics, Inc. (-0.20), less than Resilient Healthcare Corp (0), less than Radient Technologies Inc. (0), less than Thunder Energies Corporation (-0.79),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.86 | $584.46K | |
| 8.70 | $10.02M | |
| -0.11 | $35.60K | |
| -1.23 | $10.02M | |
| 1.63 | $635.92K | |
| 9.37 | $1.18M | |
| -0.20 | $1.16M | |
| 0 | $2.11M | |
| 0 | $5.40K | |
| -0.79 | $12.20K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rafarma Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rafarma Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Rafarma Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Rafarma Pharmaceuticals, Inc. (RAFA)?
What is the highest PE Ratio for Rafarma Pharmaceuticals, Inc. (RAFA)?
What is the 3-year average PE Ratio for Rafarma Pharmaceuticals, Inc. (RAFA)?
What is the 5-year average PE Ratio for Rafarma Pharmaceuticals, Inc. (RAFA)?
How does the current PE Ratio for Rafarma Pharmaceuticals, Inc. (RAFA) compare to its historical average?